Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Tenofovir and Levonorgestrel Intravaginal Rings
NCT02235662Phase 1Completed
- Sponsor
- CONRAD
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial in human immunodeficiency virus infection (HIV) and pregnancy comparing TFV IVR, TFV/LNG IVR and Placebo IVR (3 arms). Primary endpoints: Number of treatment-emergent adverse events, Systemic laboratory tests and 6 more. Started Oct 2014; status: completed.
02
Drugs
tenofoviravatrombopag
03
Conditions
human immunodeficiency virus infection (HIV)pregnancy
Beyond the preview
Go deeper on NCT02235662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02235662.